December 13, 2022 December 13, 2022Categories News StoriesBlinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)
December 13, 2022 December 13, 2022Categories Press ReleasesPress Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)
December 11, 2022 December 11, 2022Categories Press ReleasesPress Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)
December 6, 2022 December 6, 2022Categories Press ReleasesPress Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
October 28, 2022 October 28, 2022Categories Press ReleasesPress Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting
October 26, 2022 October 26, 2022Categories Press ReleasesPress Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib
October 21, 2022 October 21, 2022Categories Press ReleasesPress Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans
October 20, 2022 October 20, 2022Categories Announcements Press ReleasesPress Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee
October 13, 2022 October 13, 2022Categories Announcements News StoriesThe September/October 2022 News from ECOG-ACRIN blog is now available
